Integrated quality control processes for cell therapy workflows

CAR-T cell remedy analysis for B cell cancers should meet FDA pointers for security, efficacy, and stability. Correct testing, together with cytokine assays, is crucial to keep away from dangers like cytokine-release syndrome in analysis settings. Improvement of cell and gene remedy analysis faces a number of bottlenecks, particularly within the characterization and QC processes that are historically handbook and time-consuming. The necessity for an automatic answer to streamline the analysis workflow and decrease handbook intervention is crucial to bettering throughput and consistency.

Learn on this Utility Be aware learn how to automate plate preparation of Luminex^® multiplex immunoassays, such because the Invitrogen™ ProcartaPlex™ immunoassay to considerably scale back hands-on time whereas standardizing workflows when measuring cytokines and different biomarkers on the Luminex xMAP^® System.

Thermo Fisher Scientific is a companion of Luminex.